{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:16:24Z","timestamp":1761167784713,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"AFTAM"},{"DOI":"10.13039\/501100001742","name":"United States-Israel Binational Science Foundation","doi-asserted-by":"publisher","award":["2013282"],"award-info":[{"award-number":["2013282"]}],"id":[{"id":"10.13039\/501100001742","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.ghir.2017.11.004","type":"journal-article","created":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T19:01:59Z","timestamp":1511550119000},"page":"6-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Differential expression of IGFBPs in Laron syndrome-derived lymphoblastoid cell lines: Potential correlation with reduced cancer incidence"],"prefix":"10.1016","volume":"39","author":[{"given":"Lina","family":"Somri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rive","family":"Sarfstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena","family":"Lapkina-Gendler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karthik","family":"Nagaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zvi","family":"Laron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon A.","family":"Bach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haim","family":"Werner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2017.11.004_bb0005","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1210\/jc.2003-031033","article-title":"Extensive personal experience. Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003","volume":"89","author":"Laron","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"year":"2011","series-title":"Laron Syndrome\u2014From Man to Mouse","author":"Laron","key":"10.1016\/j.ghir.2017.11.004_bb0010"},{"key":"10.1016\/j.ghir.2017.11.004_bb0015","first-page":"152","article-title":"Genetic pituitary dwarfism with high serum concentration of growth hormone-a new inborn error of metabolism?","volume":"2","author":"Laron","year":"1966","journal-title":"Isr. J. Med. Sci."},{"key":"10.1016\/j.ghir.2017.11.004_bb0020","first-page":"989","article-title":"Laron dwarfism and mutations of the growth hormone-receptor gene, New England","volume":"321","author":"Amselem","year":"1989","journal-title":"J. Med."},{"key":"10.1016\/j.ghir.2017.11.004_bb0025","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1073\/pnas.86.20.8083","article-title":"Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism","volume":"86","author":"Godowski","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ghir.2017.11.004_bb0030","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.tem.2008.03.003","article-title":"IGF signaling defects as causes of growth failure and IUGR","volume":"19","author":"Klammt","year":"2008","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.11.004_bb0035","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.279.5350.563","article-title":"Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study","volume":"279","author":"Chan","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ghir.2017.11.004_bb0040","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(97)10384-1","article-title":"Circulating concentrations of insulin-like growth factor-I and risk of breast cancer","volume":"351","author":"Hankinson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2017.11.004_bb0045","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0140-6736(04)16044-3","article-title":"Insulin-like growth factor-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis","volume":"363","author":"Renehan","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2017.11.004_bb0050","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.tem.2006.08.006","article-title":"Obesity and cancer risk: the role of the insulin-IGF axis","volume":"17","author":"Renehan","year":"2006","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.11.004_bb0055","first-page":"2","article-title":"The pathophysiological significance of IGF-I receptor overexpression: new insights","volume":"7","author":"Werner","year":"2009","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.ghir.2017.11.004_bb0060","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1038\/onc.2011.447","article-title":"Tumor suppressors govern insulin-like growth factor signaling pathways: implications in metabolism and cancer","volume":"31","author":"Werner","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.ghir.2017.11.004_bb0065","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ghir.2006.10.007","article-title":"Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: a preliminary report","volume":"17","author":"Shevah","year":"2007","journal-title":"Growth Hormon. IGF Res."},{"key":"10.1016\/j.ghir.2017.11.004_bb0070","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1530\/EJE-10-0859","article-title":"Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies","volume":"164","author":"Steuerman","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2017.11.004_bb0075","first-page":"6","article-title":"Fifty years on: new lessons from Laron syndrome","volume":"19","author":"Werner","year":"2017","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.ghir.2017.11.004_bb0080","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrc3720","article-title":"IGF binding proteins in cancer: mechanistic and clinical insights","volume":"14","author":"Baxter","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ghir.2017.11.004_bb0085","first-page":"521","article-title":"Insulin-like growth factor binding proteins\u2014an update","volume":"13","author":"Bach","year":"2015","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.ghir.2017.11.004_bb0090","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-149-7-200810070-00006","article-title":"Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies","volume":"149","author":"Roddam","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ghir.2017.11.004_bb0095","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s10549-009-0609-5","article-title":"Serum insulin-like growth factor (IGF)-1 and IGF binding protein-3 in relation to breast cancer among Hispanic and white, non-Hispanic women in the US Southwest","volume":"121","author":"Rollison","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ghir.2017.11.004_bb0100","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ghir.2007.08.005","article-title":"Assessing the potential usefulness of IGF-related peptides and adiponectin for predicting disease risk","volume":"18","author":"Belobrajdic","year":"2008","journal-title":"Growth Hormon. IGF Res."},{"key":"10.1016\/j.ghir.2017.11.004_bb0105","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1038\/sj.onc.1209977","article-title":"Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis","volume":"26","author":"Liu","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ghir.2017.11.004_bb0110","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1530\/ERC-16-0054","article-title":"Identification of signaling pathways associated with cancer protection in Laron syndrome","volume":"23","author":"Lapkina-Gendler","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ghir.2017.11.004_bb0115","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001845","article-title":"Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans","volume":"3","author":"Guevara-Aguirre","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ghir.2017.11.004_bb0120","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1210\/jcem.74.4.1372321","article-title":"Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients","volume":"74","author":"Fielder","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.11.004_bb0125","first-page":"56","article-title":"The insulin-like growth factor (IGF)-binding proteins and IGF bioactivity in Laron-type dwarfism","volume":"74","author":"Cotterill","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.11.004_bb0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/apa.1991.80.s377.115","article-title":"Effects of exogenous insulin-like growth factor I on insulin-like growth factor binding proteins in a case of growth hormone insensitivity (Laron-type)","volume":"377","author":"Gourmelen","year":"1991","journal-title":"Acta Paediatr. Scand. Suppl."},{"key":"10.1016\/j.ghir.2017.11.004_bb0135","series-title":"Laron syndrome: From Man to Mouse","article-title":"IGF-I binding proteins in Laron syndrome","author":"Laron","year":"2011"},{"key":"10.1016\/j.ghir.2017.11.004_bb0140","first-page":"707","article-title":"Human leukemic T and B lymphoblasts produce insulin-like growth factor binding proteins 2 and 4","volume":"124","author":"Neely","year":"1991","journal-title":"Acta Endocrinol."},{"key":"10.1016\/j.ghir.2017.11.004_bb0145","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/bjc.1998.525","article-title":"Elevated serum levels of IGFBP-2 found in children suffering from acute leukaemia is accompanied by the occurrence of IGFBP-2 mRNA in the tumour clone","volume":"78","author":"Wex","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ghir.2017.11.004_bb0150","first-page":"168","article-title":"The expression of insulin-like growth factors and their binding proteins in normal human lymphocytes","volume":"128","author":"Nyman","year":"1993","journal-title":"Acta Endocrinol."},{"key":"10.1016\/j.ghir.2017.11.004_bb0155","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1210\/en.2010-1122","article-title":"Insulin-like growth factor-binding protein-3 mediates high glucose-induced apoptosis by increasing oxidative stress in proximal tubular epithelial cells","volume":"152","author":"Yoo","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2017.11.004_bb0160","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1074\/mcp.M500032-MCP200","article-title":"Proteomic identification of insulin-like growth factor-binding protein-6 induced by sublethal H2O2 stress from human diploid fibroblasts","volume":"4","author":"Xie","year":"2005","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ghir.2017.11.004_bb0165","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.humimm.2004.10.014","article-title":"Effects of insulin-like growth factors and insulin-like growth factor binding protein-2 on the in vitro proliferation of peripheral blood mononuclear cells","volume":"66","author":"Hettmer","year":"2005","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.ghir.2017.11.004_bb0170","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1165\/rcmb.2008-0211OC","article-title":"The pro-fibrotic factor IGFBP-5 induces lung fibroblast and mononuclear cell migration","volume":"41","author":"Yasuoka","year":"2009","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ghir.2017.11.004_bb0175","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.18338","article-title":"Human monocyte-derived dendritic cells exposed to hyperthermia show a distinct gene expression profile and selective upregulation of IGFBP6","author":"Liso","year":"2017","journal-title":"Oncotarget"}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637417301065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637417301065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:51:05Z","timestamp":1761087065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637417301065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":35,"alternative-id":["S1096637417301065"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2017.11.004","relation":{},"ISSN":["1096-6374"],"issn-type":[{"type":"print","value":"1096-6374"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential expression of IGFBPs in Laron syndrome-derived lymphoblastoid cell lines: Potential correlation with reduced cancer incidence","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2017.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}